Rebecca Engels took on the role of Project Manager GO-Bio initial in September. She is responsible for implementing the ‘Life Science Digital Hub‘, for which Ascenion has received BMBF funding. The aim is to support very early commercialization ideas from the drawing board. Ascenion’s core concept is to employ various digital formats to improve…
The event is organized by BioM and brings together founders, start-up enthusiasts, experienced entrepreneurs, corporates and investors to foster the exchange of knowledge, to inspire and to empower, and to celebrate life-science entrepreneurship. Dr Claus Schulte, Business Development Manager Projects & Start-Ups at Ascenion, will give a talk…
25 August 2021, Munich – Cardior Pharmaceuticals has closed a Series B financing round totalling EUR 64 million (USD 76 million). The round was led by Inkef Capital, supported by fellow new investors Fund+, Sunstone, Hadean Ventures and Coparion with participation from existing investors including LSP, BioMed Partners, Bristol Myers Squibb, and…
Research teams around Ulrich Elling at the Institute for Molecular Biotechnology (IMBA) and Luisa Cochella at the Research Institute of Molecular Pathology (IMP) have succeeded in combining the sensitivity of PCR diagnostics with the high-throughput advantages of Next Generation Sequencing (NGS). Their SARSeq method can process tens of thousands…
x-c-bleeding is the first of x-cardiac’s products to receive market authorization. A second product, x-c-renal-injury, is under development. Both employ AI-based algorithms to collate and evaluate data from various monitoring instruments, allowing potential critical complications, such as post-operative bleeding or acute renal failure, to be…
The trial will enroll 48 healthy volunteers to assess the candidate’s safety, tolerability and pharmacokinetics. Results are expected later this year.
HRX-0215 targets MKK4, a key regulator of liver regeneration, and is the first representative of the company’s drug discovery platform to enter clinical testing.
The therapeutic concept was…
San Francisco, CA / Berlin, 2 August 2021 - T-knife Therapeutics, Inc., a next-generation T-cell receptor company developing innovative therapeutics for solid tumor patients, today announced the successful completion of a $110 million Series B financing. The financing was led by Fidelity Management & Research Company, LLC., with participation…
Many new diseases emerge through the mutual transmission of pathogens between humans and animals. Increasing mobility, disappearing habitats, industrial agriculture and intensive livestock farming increase the risk of rapid world-wide spread. Research into fundamental relationships and the development of interventions for sustainable health…
One of the first pioneers of German bioinformatics, Biomax Informatics AG was launched over 20 years ago. Since then, the company has developed from a supplier of specialist genome annotation software to an integrated provider of solutions for knowledge management in the life sciences. It has established key technologies in semantic search, brain…
At the heart of this innovative approach is an algorithm developed by Prof. Alexander Meyer, physician and computer scientist at the German Heart Center Berlin (DHZB) and cofounder of x-cardiac. The software collates data from various monitoring instruments in modern intensive care units and evaluates them intelligently, allowing potential…
Most conventional molecular tests, including the current PCR tests for Corona detection, identify just one disease-related marker. The results show whether SARS-CoV-2 is present or not, but provide no further details. The technology developed by HIRI and JMU scientists presents a new, highly multiplexable approach. It allows an almost infinite…
This May, ASTP conference will return as an online event welcoming hundreds of knowledge transfer professionals from Europe and beyond. With inspiring keynote speakers and a packed programme, it provides a unique opportunity for sharing, learning and networking.
For the first time, the conference will kick off with a half-day interactive session…
30 April 2021, Munich – This year’s virtual BioVaria from 26 to 28 April brought together 250 life-science innovators to hear about the most exciting technologies and start-ups to emerge from publicly funded European research, and to initiate partnerships between science and business. With 75 licensable projects and 16 selected start-ups, this was…
News Services
Do you wish to keep informed on Ascenion's News? Then register for our newsletters.
News Ascenion
Projects, Partners, Technology Transfer
Technology Alert
Technology offers for your areas of interest
News BioVaria
Programme highlights and deadlines
Science4Life
Science4Life is a German initiative to support founders of start-up companies in the field of Life Sciences and Chemistry.
hannoverimpuls
A joint business development company run by Hannover city and region. It offers a range of services from an entrepreneurs’ workshop, seminars and a competition, to the provision…
